 |
Biosketch
Dr. Rosenberg's research focuses on developing new treatments for Alzheimer’s Disease (AD) especially neuropsychiatric symptoms and relevant biomarkers including sleep and circadian rhythm.
Dr. Rosenberg is a 2008 Paul Beeson Scholar, chaired the NIA-N SRG at the National Institute on Aging, and served on the FDA Advisory Committee for Peripheral and Central Nervous System Drugs.
He trained in Adult Psychiatry at Tufts University/New England Medical Center and Geriatric Psychiatry at Mclean Hospital.
Affiliation
- Professor, Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Baltimore, Maryland
|